77
Participants
Start Date
June 30, 2003
Primary Completion Date
November 30, 2007
Study Completion Date
March 31, 2009
Pirfenidone
Pirfenidone will be administered orally at 1200 or 2400 mg day in divided doses
The Center for Diabetic Kidney Disease at Thomas Jefferson University, Philadelphia
National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), Bethesda
Mayo Clinic, Rochester
National Institutes of Health (NIH)
NIH
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Sharma, Kumar, M.D.
INDIV